The patient reported pain around where the neurostimulators were coiled.There were no signs of infection, the incisions healed nicely, and the neurostimulators did not migrate.Additionally, there were multiple conversations with the patient regarding therapy, but the patient was unwilling to turn the device on.An explant procedure was performed on (b)(6) 2024, and the patient is doing well.
|
The other adverse events issue questionnaire was reviewed for potential causes of the reported issue.Based on this review, implanting the device at an off-label location, implanting the device too close to the targeted nerve, migration, and bone or tissue inadvertently punctured during the procedure have been ruled out as potential causes.However, the patient was extremely thin classifying the patient as a poor candidate.The stimulator is used to treat pain.The cause of the reported issue is due to the patient being a poor candidate due to health, weight, age, or mental capacity as the patient was extremely thin (user error-clinician).Rates reviewed at the most recent complaint trending meeting do not indicate a significant increase in other adverse events issues.Other adverse events issues rates remain acceptably low; thus, a capa is not required.Other adverse events issues rates will continue to be tracked and trended.Refer to (b)(4) for additional investigation details and risk assessment for late mdr reporting.
|